Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
GE.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GE.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
V.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
V.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
V.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.149ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.149ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.149ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.149NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.413ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.413ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.413NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.9.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.107ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.107ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.107NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.10 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.10 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.10 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.10 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used